NuvaMed connects patients with independent, licensed physicians for GLP-1 weight loss and men's health treatment — no waiting rooms, no video calls required, no guesswork. Every prescription decision is made by a real physician, not an algorithm.
Millions of people who could benefit from GLP-1 or men's health treatment never start, because getting care means taking time off work, sitting in a waiting room, or navigating insurance denials. NuvaMed exists to remove those barriers while keeping the part that matters most — a licensed physician reviewing your health history and making the medical decision — fully intact.
We built our platform around a simple standard: convenience should never come at the cost of medical rigor. Every intake is reviewed individually. Every prescription is written by a physician licensed in your state. Every medication ships from an accredited pharmacy.
NuvaMed is a technology platform, not a pharmacy or a medical practice. We connect you with an independent physician network and a compounding pharmacy network, and we build the software that makes that connection fast and secure.
Every treatment plan is reviewed and approved by a board-certified physician licensed to practice in your state. Physicians — not NuvaMed — make every diagnostic and prescribing decision.
Medications are dispensed by independent, licensed U.S. pharmacies meeting the quality and regulatory standards required of any licensed pharmacy.
Your health information is encrypted in transit and at rest, access is restricted to the parties involved in your care, and we never sell your data.
One flat monthly price with no hidden fees, no membership required, and a 30-day money-back guarantee if your plan isn't approved or isn't right for you.
We only offer medications with strong clinical backing. Our GLP-1 programs use FDA-approved semaglutide (Wegovy®) and tirzepatide (Zepbound®) — studied in the STEP and SURMOUNT clinical trial programs. In clinical trials, patients taking semaglutide 2.4 mg lost an average of about 15% of body weight over 68 weeks, and patients taking tirzepatide lost up to about 20% over 72 weeks. Individual results vary, and medication works best alongside nutrition and activity changes. Our men's health programs use generic sildenafil and generic tadalafil, both FDA-approved active ingredients for erectile dysfunction.
You can review the clinical data referenced on each treatment page: Semaglutide, Tirzepatide, Sildenafil, and Tadalafil. Wegovy® is a trademark of Novo Nordisk; Zepbound® is a trademark of Eli Lilly. NuvaMed is not affiliated with or endorsed by Novo Nordisk or Eli Lilly.
Our care team is available at help@nuvamed.org for anything not covered in our FAQ. If you're ready, the free assessment takes about five minutes and puts you in front of a physician within 24 hours.
Take the free assessment — no payment required until a physician approves your plan.
Start Your Free Assessment →No spam. Unsubscribe anytime.